Atria Investments’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Sell
18,692
-7,487
-29% -$283K 0.01% 1294
2025
Q4
$1.01M Sell
26,179
-1,685
-6% -$64.9K 0.01% 1057
2025
Q3
$1.04M Sell
27,864
-24
-0.1% -$831 0.01% 1033
2025
Q2
$909K Buy
27,888
+4,185
+18% +$119K 0.01% 1085
2025
Q1
$716K Sell
23,703
-1,423
-6% -$50.4K 0.01% 1161
2024
Q4
$907K Buy
25,126
+3,593
+17% +$132K 0.01% 1025
2024
Q3
$759K Sell
21,533
-2,620
-11% -$87.6K 0.01% 1119
2024
Q2
$822K Buy
+24,153
New +$748K 0.01% 1039

Other funds holding HCMT

Atria Investments's HCMT Position: Q1 2026 in Review

Atria Investments reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 29% in Q1 2026, selling an estimated $283K and leaving 18,692 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #1294.

Atria Investments first reported a position in HCMT in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.04M in Q3 2025. 36 funds tracked by Wall St. Rank hold HCMT as of Q1 2026.

  • Atria Investments held 18,692 shares of Direxion HCM Tactical Enhanced US ETF worth $658K as of Q1 2026.
  • Atria Investments sold 7,487 Direxion HCM Tactical Enhanced US ETF shares in Q1 2026, an estimated $283K.
  • Direxion HCM Tactical Enhanced US ETF made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1294 holding.
  • Atria Investments first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Direxion HCM Tactical Enhanced US ETF position peaked at $1.04M in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.